Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA)
Virchis
A
A
Mehta
A
A
D015762:2-Chloroadenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003839:Deoxyadenosines / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000628:therapy*
D000964:Antimetabolites, Antineoplastic; D003839:Deoxyadenosines; D015762:2-Chloroadenosine; C055994:2-chloro-3'-deoxyadenosine